CES3
Basic information
Region (hg38): 16:66961245-66975149
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CES3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 34 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 6 | 0 |
Variants in CES3
This is a list of pathogenic ClinVar variants found in the CES3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-66963184-G-A | not specified | Likely benign (May 11, 2022) | ||
16-66963187-G-A | not specified | Uncertain significance (Aug 17, 2022) | ||
16-66963205-G-T | not specified | Uncertain significance (May 23, 2023) | ||
16-66963227-G-A | not specified | Uncertain significance (Apr 18, 2023) | ||
16-66963283-A-G | not specified | Uncertain significance (Jan 24, 2023) | ||
16-66963299-C-T | not specified | Uncertain significance (Nov 13, 2024) | ||
16-66963308-G-A | not specified | Uncertain significance (Oct 06, 2024) | ||
16-66963315-C-G | not specified | Uncertain significance (Dec 03, 2024) | ||
16-66963316-C-T | not specified | Uncertain significance (Feb 27, 2023) | ||
16-66963337-G-T | not specified | Uncertain significance (Nov 18, 2024) | ||
16-66963492-T-G | not specified | Uncertain significance (Dec 08, 2023) | ||
16-66963537-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
16-66963587-C-A | not specified | Uncertain significance (Dec 28, 2023) | ||
16-66963881-G-A | not specified | Uncertain significance (Oct 26, 2021) | ||
16-66963892-G-A | not specified | Uncertain significance (May 10, 2024) | ||
16-66963910-C-T | not specified | Uncertain significance (Jun 07, 2024) | ||
16-66963911-G-A | not specified | Likely benign (Jan 31, 2022) | ||
16-66964404-T-A | not specified | Uncertain significance (Apr 26, 2023) | ||
16-66964415-C-T | not specified | Uncertain significance (Dec 07, 2021) | ||
16-66964424-C-A | not specified | Uncertain significance (May 01, 2024) | ||
16-66964436-G-A | not specified | Likely benign (Jun 07, 2023) | ||
16-66964437-C-T | not specified | Uncertain significance (Feb 15, 2023) | ||
16-66964448-G-A | not specified | Uncertain significance (Aug 01, 2024) | ||
16-66964485-C-G | not specified | Uncertain significance (Mar 04, 2024) | ||
16-66964704-T-C | not specified | Uncertain significance (Jul 14, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CES3 | protein_coding | protein_coding | ENST00000303334 | 13 | 13912 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.34e-12 | 0.236 | 125550 | 1 | 197 | 125748 | 0.000788 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.526 | 319 | 347 | 0.920 | 0.0000200 | 3726 |
Missense in Polyphen | 124 | 125.29 | 0.98973 | 1522 | ||
Synonymous | 0.0188 | 138 | 138 | 0.998 | 0.00000881 | 1136 |
Loss of Function | 0.973 | 21 | 26.4 | 0.796 | 0.00000132 | 272 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00465 | 0.00459 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00261 | 0.00261 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000432 | 0.000431 |
Middle Eastern | 0.00261 | 0.00261 |
South Asian | 0.000556 | 0.000523 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in the detoxification of xenobiotics and in the activation of ester and amide prodrugs. Shows low catalytic efficiency for hydrolysis of CPT-11 (7-ethyl-10-[4-(1-piperidino)- 1-piperidino]-carbonyloxycamptothecin), a prodrug for camptothecin used in cancer therapeutics.;
- Pathway
- Aryl Hydrocarbon Receptor Pathway;Nuclear Receptors Meta-Pathway;NRF2 pathway;Phase I - Functionalization of compounds;Biological oxidations;Metabolism;LDL clearance;Plasma lipoprotein clearance;Transport of small molecules;Plasma lipoprotein assembly, remodeling, and clearance;E2F transcription factor network
(Consensus)
Intolerance Scores
- loftool
- 0.935
- rvis_EVS
- 0.23
- rvis_percentile_EVS
- 68.52
Haploinsufficiency Scores
- pHI
- 0.0560
- hipred
- N
- hipred_score
- 0.153
- ghis
- 0.402
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.672
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ces3b
- Phenotype
Zebrafish Information Network
- Gene name
- ces3
- Affected structure
- otolith
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- xenobiotic metabolic process;lipid catabolic process;low-density lipoprotein particle clearance
- Cellular component
- extracellular space;endoplasmic reticulum lumen;cytosol;extracellular exosome
- Molecular function
- sterol esterase activity;triglyceride lipase activity;carboxylic ester hydrolase activity